Alexander Aliper (Alex Aliper)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Papillary Thyroid

Top Venues

Journal of medicinal chemistry

Journal of chemical information and modeling

PLoS computational biology

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Maksim Kuznetsov, Fedor Ryabov, Roman S Schutski, Rim Shayakhmetov, Yen-Chu Lin, Alexander Aliper, Daniil Polykovskiy
COSMIC: Molecular Conformation Space Modeling in Internal Coordinates with an Adversarial Framework. Journal of chemical information and modeling 64 (9) (2024)
Jianyu Xu, Xiaoyu Ding, Yanyun Fu, Qingyuan Meng, Ling Wang, Man Zhang, Chenxi Xu, Shan Chen, Alexander Aliper, Feng Ren, Alex Zhavoronkov, Xiao Ding
Discovery of Novel and Potent Prolyl Hydroxylase Domain-Containing Protein (PHD) Inhibitors for The Treatment of Anemia. Journal of medicinal chemistry (2024)
Maksim Kuznetsov, Fedor Ryabov, Roman S Schutski, Rim Shayakhmetov, Yen-Chu Lin, Alexander Aliper, Daniil Polykovskiy
COSMIC: Molecular Conformation Space Modeling in Internal Coordinates with an Adversarial Framework. Journal of chemical information and modeling (2024)
Jianyu Xu, Hongyun Qi, Zhen Wang, Ling Wang, Barbara Steurer, Xin Cai, Jinxin Liu, Alexander Aliper, Man Zhang, Feng Ren, Alex Zhavoronkov, Xiao Ding
Discovery of a Novel and Potent Cyclin-Dependent Kinase 8/19 (CDK8/19) Inhibitor for the Treatment of Cancer. Journal of medicinal chemistry (2024)
Maksim Kuznetsov, Fedor Ryabov, Roman S Schutski, Rim Shayakhmetov, Yen-Chu Lin, Alexander Aliper, Daniil Polykovskiy
COSMIC: Molecular Conformation Space Modeling in Internal Coordinates with an Adversarial Framework. Journal of chemical information and modeling 64 (9) (2024)
Jianyu Xu, Xiaoyu Ding, Yanyun Fu, Qingyuan Meng, Ling Wang, Man Zhang, Chenxi Xu, Shan Chen, Alexander Aliper, Feng Ren, Alex Zhavoronkov, Xiao Ding
Discovery of Novel and Potent Prolyl Hydroxylase Domain-Containing Protein (PHD) Inhibitors for The Treatment of Anemia. Journal of medicinal chemistry 67 (2) (2024)
Jianyu Xu, Xiaoyu Ding, Yanyun Fu, Qingyuan Meng, Ling Wang, Man Zhang, Chenxi Xu, Shan Chen, Alexander Aliper, Feng Ren, Alex Zhavoronkov, Xiao Ding
Discovery of Novel and Potent Prolyl Hydroxylase Domain-Containing Protein (PHD) Inhibitors for The Treatment of Anemia. Journal of medicinal chemistry 67 (2) (2024)
Jianyu Xu, Hongyun Qi, Zhen Wang, Ling Wang, Barbara Steurer, Xin Cai, Jinxin Liu, Alexander Aliper, Man Zhang, Feng Ren, Alex Zhavoronkov, Xiao Ding
Discovery of a Novel and Potent Cyclin-Dependent Kinase 8/19 (CDK8/19) Inhibitor for the Treatment of Cancer. Journal of medicinal chemistry 67 (10) (2024)
Maksim Kuznetsov, Fedor Ryabov, Roman S Schutski, Rim Shayakhmetov, Yen-Chu Lin, Alexander Aliper, Daniil Polykovskiy
COSMIC: Molecular Conformation Space Modeling in Internal Coordinates with an Adversarial Framework. Journal of chemical information and modeling 64 (9) (2024)
Yan A Ivanenkov, Bogdan Zagribelnyy, Alex Malyshev, Sergei Evteev, Victor Terentiev, Petrina Kamya, Dmitry Bezrukov, Alexander Aliper, Feng Ren, Alex Zhavoronkov
The Hitchhiker's Guide to Deep Learning Driven Generative Chemistry. ACS medicinal chemistry letters 14 (7) (2023)
Yazhou Wang, Chao Wang, Tingting Liu, Hongyun Qi, Shan Chen, Xin Cai, Man Zhang, Alexander Aliper, Feng Ren, Xiao Ding, Alex Zhavoronkov
Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer. Journal of medicinal chemistry 67 (1) (2023)
Yazhou Wang, Chao Wang, Tingting Liu, Hongyun Qi, Shan Chen, Xin Cai, Man Zhang, Alexander Aliper, Feng Ren, Xiao Ding, Alex Zhavoronkov
Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer. Journal of medicinal chemistry 67 (1) (2023)
Yazhou Wang, Chao Wang, Tingting Liu, Hongyun Qi, Shan Chen, Xin Cai, Man Zhang, Alexander Aliper, Feng Ren, Xiao Ding, Alex Zhavoronkov
Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer. Journal of medicinal chemistry 67 (1) (2023)
Yazhou Wang, Chao Wang, Tingting Liu, Hongyun Qi, Shan Chen, Xin Cai, Man Zhang, Alexander Aliper, Feng Ren, Xiao Ding, Alex Zhavoronkov
Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer. Journal of medicinal chemistry (2023)
Vladimir Naumov, Evgeny Putin, Stefan Pushkov, Ekaterina Kozlova, Konstantin Romantsov, Alexander Kalashnikov, Fedor Galkin, Nina Tihonova, Anastasia Shneyderman, Egor Galkin, Arsenii Zinkevich, Stephanie M Cope, Ramanathan Sethuraman, Tudor I Oprea, Alexander T Pearson, SavaÅŸ Tay, Nishant Agrawal, Alexey Dubovenko, Quentin Vanhaelen, Ivan Ozerov, Alexander Aliper, Evgeny Izumchenko, Alex Zhavoronkov
COVIDomic: A multi-modal cloud-based platform for identification of risk factors associated with COVID-19 severity. PLoS computational biology 17 (7) (2021)
Daniil Polykovskiy, Alexander Zhebrak, Dmitry Vetrov, Yan A Ivanenkov, Vladimir Aladinskiy, Polina Mamoshina, Marine E Bozdaganyan, Alexander Aliper, Alex Zhavoronkov, Artur Kadurin
Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery. Molecular pharmaceutics 15 (10) (2018)